In a prior study examining the relationship between BC cells and ADAMTS9, hypericin’s potential antitumor effects may be attributed to its interaction with ADAMTS1, ADAMTS3, and ADAMTS9, considering the apoptotic and extracellular effects of ADAMTS9 and the antiangiogenic properties of ADAMTS1 [89]. This evidence concerns the gene ADAMTS9 and breast cancer.